Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02003 (
NBT
)
1,323
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The regulatory role of MEF2 (myocyte enhancer binding factor 2) proteins in nonmuscle tissues has not been well characterized. We examined the expression of MEF2 family members, namely, MEF2A, -B, -C, and -D, in the differentiation of HL60 promyeloid cells and observed the remarkable increase in the expressions of MEF2A and
MEF2D
proteins during the differentiation process into monocytes. To examine the role of MEF2, we expressed a dominant-negative form of
MEF2D
, without its transactivation domain, in HL60 cells. When the HL60 cell line expressing the mutant
MEF2D
was induced to differentiate by VitD(3) treatment, cell surface expression of CD14 and the ability to reduce
NBT
, which are important characteristics of differentiated monocytes, were significantly decreased compared with control HL60 cells. These results show that
MEF2D
is required in the differentiation process along the monocyte/macrophage lineage,
...
PMID:Requirement of MEF2D in the induced differentiation of HL60 promyeloid cells. 1068 60